DIRS.INFO The most relevant business & tech news

☆ Bristol Myers Squibb tops earnings estimates and hikes outlook, helped by Eliquis and new drugs
▼ + stars: | 2024-10-31 | by ( Annika Kim Constantino | ) www.cnbc.com time to read: +3 min

The Bristol Myers Squibb research and development center at Cambridge Crossing in Cambridge, Massachusetts, US, on Wednesday, Dec. 27, 2023. Bristol Myers Squibb on Thursday reported third-quarter earnings and revenue that blew past Wall Street's expectations thanks to its blockbuster blood thinner Eliquis and a portfolio of drugs it expects to deliver long-term growth. Bristol Myers previously said it expected sales to rise in the "upper end" of the low single-digit range. The results come as Bristol Myers moves to cut $1.5 billion in costs by 2025 and funnel that money into key drug brands and research and development programs. Notably, the Food and Drug Administration approved Bristol Myers Squibb's highly anticipated schizophrenia drug Cobenfy during the quarter.

Persons: Bristol Myers, Joe Biden's, Bristol Myers Squibb's Organizations: Bristol Myers Squibb, LSEG, Food and Drug Administration, Bristol Locations: Cambridge, Cambridge , Massachusetts, Eliquis

☆ Apple to report earnings as investors worry about 'mixed' iPhone demand
▼ + stars: | 2024-10-31 | by ( Kif Leswing | ) www.cnbc.com time to read: +4 min

Apple CEO Tim Cook inspects the new iPhone 16 during an Apple special event at Apple headquarters on September 09, 2024 in Cupertino, California. "That should be expected, as Apple Intelligence features (the only reason to upgrade)have yet to be rolled out in a significant way." U.S. carriers, including AT&T, Verizon and T-Mobile, have also seemed unexcited about an Apple Intelligence upgrade cycle. But research firm Counterpoint Research told CNBC in October that iPhone sales, especially for the lower-priced devices, were strong in China. WATCH: Apple Intelligence rollout could be an inflection point, says Futurum Group CEO's Daniel Newman

Persons: Tim Cook, Apple doesn't, Morgan Stanley, Erik Woodring, Davidson, Gil Luria, We're, John Stankey, Malif Atik, Apple, Luca Maestri, Maestri, Kevan Parekh, CEO's Daniel Newman Organizations: Apple, Apple Intelligence, Verizon, Mobile, Huawei, Citi, Research, CNBC, Apple Watch, LSEG, Major League Soccer Locations: Cupertino , California, Spanish, U.S, China, Apple's

☆ Meta is 'best early GenAI winner': Analysts stick by tech giant despite spending concerns
▼ + stars: | 2024-10-31 | by ( Pia Singh | In | ) www.cnbc.com time to read: +4 min

Analysts think there's still room for Meta shares to run, even after the company posted disappointing metrics in its latest quarterly report . Wall Street majors are largely optimistic on Meta over the next year, with most firms assigning a price target that implies at least 5% upside. META remains best early GenAI winner in the group," Morgan Stanley analyst Brian Nowak wrote in a note to clients. Shmulik has a price target on the high range of the Street. "We're constructive on the core business, we believe Meta can continue delivering revenue growth above expectations."

Persons: Bernstein, Goldman Sachs, Morgan Stanley, Brian Nowak, " Nowak, Deutsche Bank's Benjamin Black, Mark Shmulik, Shmulik, Meta Organizations: Meta, Facebook, Wall, Lab, Reality Labs, Bank of America, Barclays, Citi, Deutche, Deutsche, — Locations: U.S

☆ Microsoft's stock heads for worst day in two years after disappointing forecast
▼ + stars: | 2024-10-31 | by ( Jordan Novet | ) www.cnbc.com time to read: +2 min

Microsoft CEO Satya Nadella speaks at a company event on artificial intelligence technologies in Jakarta, Indonesia, on April 30, 2024. Microsoft 's better-than-expected earnings report wasn't enough to prevent the stock's steepest selloff in two years, as investors instead focused on the company's forecast for the current period. Microsoft shares fell more than 5% on Thursday and headed for their worst day since Oct. 26, 2022, when they dropped 7.7%. Amazon , which leads the cloud infrastructure market, is scheduled to report results after the close on Thursday. Net income rose 11% to $24.67 billion from $22.29 billion in the year-ago quarter.

Persons: Satya Nadella, Amy Hood Organizations: Microsoft, Revenue, Google, BofA Global Research Locations: Jakarta, Indonesia

☆ Don't be alarmed by conservative guidance after a solid quarter, Jim Cramer says
▼ + stars: | 2024-10-31 | by ( Julie Coleman | ) www.cnbc.com time to read: +2 min

CNBC's Jim Cramer on Thursday told investors not to get scared off when a company posts good earnings results but issues more modest guidance, as it doesn't always mean that management is worried about the future. "Some money managers are dumbfounded when a very good company reports a very good quarter but then issues a very conservative forecast," Cramer said. Sometimes, he said, it's worth it to hold on to a company with good earnings while others on Wall Street panic about guidance. For the current quarter, Microsoft predicted revenue between $68.1 billion and $69.1 billion, while analysts surveyed by LSEG were hoping for $69.83 billion. Despite the disappointing guidance, Cramer was appeased by management's explanation for the weaker guidance, particularly commentary from CFO Amy Hood.

Persons: CNBC's Jim Cramer, Cramer, management's, LSEG, Amy Hood, Hood, she's Organizations: Microsoft

☆ Intel shares jump 9% on earnings beat, uplifting guidance
▼ + stars: | 2024-10-31 | by ( Jordan Novet | ) www.cnbc.com time to read: +3 min

Intel shares rose 9% in extended trading on Thursday after the chipmaker reported better-than-expected earnings and issued quarterly guidance that topped estimates. Intel called for fiscal third-quarter adjusted earnings of 12 cents per share and revenue between $13.3 billion and $14.3 billion. Analysts had expected 8 cents in adjusted earnings per share and $13.66 billion in revenue. During the quarter, Intel announced the launch of Xeon 6 server processors and Gaudi artificial intelligence accelerators. As of Thursday's close, Intel shares were down about 57% in 2024, while the S&P 500 index had gained 20%.

Persons: Pat Gelsinger, Dave Zinsner, Gaudi, Harvest's Paul Meeks Organizations: Intel, CNBC, Qualcomm, Computing, StreetAccount, Revenue, Data Center Locations: Taipei, Taiwan

☆ Beaten-up Nextracker provides investors a reason to believe. But timing is key here
▼ + stars: | 2024-10-31 | by ( Kevin Stankiewicz | ) www.cnbc.com time to read: +7 min

Nextracker lost around 32% of its value in between its August earnings report and Wednesday's close — a frustrating decline. It's too early to act, given the results of next week's contests could move shares of Nextracker and its peers considerably. "We were pleasantly surprised and gratified that this was the best solar earnings we've seen this quarter," Jim Cramer said Thursday. Nextracker Why we own it: Nextracker makes industry-leading tracking technology, which enables large-scale solar panel installations to follow the sun's movement and increase their power generation. Guidance Nextracker reaffirmed its fiscal 2025 guidance for revenue while upping its outlook for a pair of profitability metrics.

Persons: Nextracker, Jim Cramer, We're, Howard Wenger, Chuck Boynton, Jim Cramer's, Jim, Peter Cade Organizations: NXT, Club, Mizuho Securities, CNBC, Stone Locations: Nextracker

☆ Oil giant Shell posts $6 billion profit beat, launches new share buyback program
▼ + stars: | 2024-10-31 | by ( Sam Meredith | In Samuelmeredith | ) www.cnbc.com time to read: +1 min

The Shell logo is displayed outside a petrol station in Radstock in Somerset, England, on Feb. 17, 2024. British oil giant Shell on Thursday posted a small year-on-year drop in third-quarter profit as a sharp decline in crude prices and lower refining margins were partially offset by higher gas sales. The energy company reported adjusted earnings of $6 billion for the July-September period, beating analyst expectations of $5.3 billion, according to estimates compiled by LSEG. Shell posted adjusted earnings of $6.3 billion in the second quarter and $6.2 billion in the third quarter of 2023. It marks the 12th consecutive quarter that Shell has announced at least $3 billion in buybacks, Sinead Gorman, chief financial officer at Shell, said in a video presentation.

Persons: Shell, Sinead Gorman, Gorman Organizations: LSEG, Shell Locations: Radstock, Somerset, England, buybacks, London

☆ What Wall Street expects from Amazon, Apple earnings after the bell
▼ + stars: | 2024-10-31 | by ( Samantha Subin | ) www.cnbc.com time to read: +6 min

Wall Street faces another key litmus test Thursday with results from megacap technology giants Apple and Amazon . For Apple, Wall Street also wants to see its latest iPhone pick up steam, and investors seek more insight into when the company's AI initiative will begin lifting sales. For Apple, Wall Street expects EPS of $1.60 on $94.58 billion in revenue. Amazon's retail business also remains top of mind for Wall Street ahead of the busy holding shopping period. Apple For Apple, Wall Street is eagerly searching for signs of strong demand for its latest iPhone model and updates on its AI strategy.

Persons: Jason Helfstein, Brent Thill, Bank of America's Justin Post, Doug Anmuth, Goldman Sachs, Eric Sheridan, Ronald Josey, Morgan Stanley, Erik Woodring, Jefferies, Edison Lee, Samik Chatterjee, Davidson's Gil Luria, Wamsi Mohan, Tim Long, AAPL, Long Organizations: Apple, Nasdaq, Microsoft, Wall, LSEG, Amazon, StreetAccount, Jefferies, Bank of America's, Apple Intelligence, " Bank of America, Barclays Locations: Amazon

☆ Wall Street remains confident on Microsoft's AI story despite weak guidance. Some say to buy the dip
▼ + stars: | 2024-10-31 | by ( Pia Singh | In | ) www.cnbc.com time to read: +4 min

Wall Street's bullish sentiment on Microsoft hasn't faded, even after the tech giant forecast disappointing revenue growth numbers. The company's revenue increased 16% year over year in the quarter, and its net income rose 11% during the period compared to the year-ago quarter. That forecast led shares to slip nearly 4% in premarket trading, despite the company's strong earnings performance. That would be the company's fastest ever AI-related revenue growth rate. Barclays, which has one of the lowest price objectives on Wall Street, said it sees Microsoft shares being "range bound" in the short term.

Persons: Morgan Stanley —, Bernstein, Morgan Stanley, Keith Weiss, Weiss, Kirk Materne, Materne, Raimo Lenschow Organizations: Microsoft, LSEG, JPMorgan, Bank of America, Barclays, Citi, 25X, Investors Locations: Wells

☆ Comcast tops earnings estimates as Olympics propels the company
▼ + stars: | 2024-10-31 | by ( Lillian Rizzo | ) www.cnbc.com time to read: +4 min

Comcast beat third-quarter earning expectations on Thursday, as the Summer Olympics in Paris boosted NBCUniversal's revenue and Peacock's subscriber count. The company's revenue rose 6.5% to $32.07 billion compared to the same period last year. Overall revenue was boosted by the Summer Olympics in Paris, which NBCUniversal exclusively broadcast in the U.S., and domestic broadband revenue — despite continued slowing customer growth. Revenue for the media segment – mainly comprised of NBCUniversal – was up nearly 37% to $8.23 billion, largely due to the Olympics. The company's film studios, also part of the content and experiences segment, saw revenue increase 12.3% to $2.83 billion compared to the prior year.

Persons: –, Peacock, lockdowns, NBCUniversal Organizations: Comcast, LSEG, Summer, Revenue, CNBC, Paris, Olympics, Cable, Verizon, Program, ACP, Domestic, NBC Sports, NBC Olympics, NBC, Games Locations: Paris, U.S, Peacock

☆ Merck tops earnings estimates on strong demand for Keytruda, new drugs even as HPV vaccine sales fall
▼ + stars: | 2024-10-31 | by ( Annika Kim Constantino | ) www.cnbc.com time to read: +2 min

Merck on Thursday reported third-quarter revenue and adjusted earnings that topped expectations as the company saw strong sales from its top-selling cancer drug Keytruda, recently launched treatments and its animal health business. But Merck's vaccine that prevents cancer from HPV, the most common sexually transmitted infection in the U.S., posted another quarter of lighter-than-expected sales. Revenue from the shot, Gardasil, fell 11% compared to the year-earlier period, mainly due to lower demand in China. The company booked $16.66 billion in revenue for the third quarter, up 4% from the same period a year ago. The loss of exclusive rights to the medicine will likely cause sales to fall, forcing the company to draw revenue from elsewhere.

Persons: Keytruda, Curon, Merck Organizations: Merck, LSEG Locations: Rahway , New Jersey, U.S, China

☆ Stocks making biggest moves premarket: Carvana, eBay, Microsoft, Uber Technologies and more
▼ + stars: | 2024-10-31 | by ( Sean Conlon | ) www.cnbc.com time to read: +5 min

Carvana – Shares surged more than 19% on the heels of a third-quarter earnings and revenue beat . Microsoft sees revenue coming in between $68.1 billion and $69.1 billion, while analysts were estimating $69.8 billion, according to LSEG. Comcast – Shares climbed nearly 6% after the theme park and media company's third quarter earnings and revenue beat analyst estimates. Cigna – Shares advanced more than 2% after the insurer's third-quarter earnings and revenue beat analysts' expectations. Coinbase – The cryptocurrency exchange platform fell more than 2% after third-quarter earnings and revenue missed Street estimates .

Persons: Carvana, LSEG, Peter Stern, Robinhood, Meta, Cigna, FactSet, Etsy, Coinbase, —, Alex Harring, Samantha Subin, Jesse Pound, Lisa Kailai Han, Sarah Min, Michelle Fox Theobald Organizations: eBay, Ebay, –, Microsoft, Booking Holdings, Uber Technologies, Comcast, LSEG, Super, Facebook, Meta, Wall, CNBC Locations: StreetAccount, LSEG .

☆ We're hiking our price target on an industrial whose earnings benefit from AI data center boom
▼ + stars: | 2024-10-31 | by ( Zev Fima | ) www.cnbc.com time to read: +9 min

Electrical components and power systems company Eaton delivered mixed third-quarter results Thursday morning, and its stock paid the price. Eaton management raised its full-year guidance for both operating margin and earnings per share (EPS). However, we're increasing our price target to $375 per share from $350, implying over 9% upside from Wednesday's close. 2025 outlook Looking to next year, management didn't provide formal sales or earnings guidance, but they did provide growth assumptions for the company's key end markets. Industrial facilities (12% of sales), defense aerospace (6% of sales), and commercial and institutional (20% of sales) are expected to realize "modest growth."

Persons: Eaton, it's, we've, Oliveri Leonetti, Parker, wouldn't, Craig Arnold, Jefferies, Jim Cramer's, Jim Cramer, Jim Organizations: Revenue, LSEG, Boeing, Electrical, Aerospace, Hannifin, DuPont, Honeywell, CNBC, Eaton Corporation, NYSE Locations: Florida, Eaton, Americas, North America

☆ Carvana raises 2024 earnings guidance after topping Wall Street's Q3 expectations
▼ + stars: | 2024-10-30 | by ( Michael Wayland | ) www.cnbc.com time to read: +1 min

Carvana on Wednesday raised its 2024 earnings guidance after the online used-car retailer significantly topped Wall Street's third-quarter expectations. For 2024 guidance, Carvana said its adjusted earnings before interest, taxes, depreciation and amortization would be "significantly above the high end" of its previous target of $1 billion to $1.2 billion. The company reported $339 million in adjusted EBITDA last year. Adjusted EBITDA was $429 million and adjusted EBITDA margin was 11.7%, both topping company records achieved during the second quarter. The company's third-quarter 2023 results included adjusted EBITDA of $148 million and revenue of $2.77 billion.

Persons: Carvana

☆ Stocks making the biggest moves midday: Reddit, Super Micro Computer, Garmin, Snap and more
▼ + stars: | 2024-10-30 | by ( Sean Conlon | ) www.cnbc.com time to read: +6 min

Reddit reported earnings of 16 cents per share, while analysts surveyed by LSEG had expected a loss of 7 cents. For the period, Garmin posted pro forma earnings of $1.99 per share on $1.59 billion in revenue. Wingstop – Shares fell around 19% after the restaurant chain missed analysts' expectations for the third quarter. Wingstop earned 88 cents per share, while analysts were looking for 95 cents per share, per LSEG. Advanced Micro Devices – Shares tumbled 9.5% after AMD gave guidance for fourth-quarter revenue of $7.5 billion, in line with analysts expectations, per LSEG.

Persons: Reddit, LSEG, EY, FactSet, Eli Lilly, XPO, Shack, Thomas Reeg, Wingstop, Chipotle, StreetAccount, Raymond James, Goldman Sachs, Alex Harring, Samantha Subin, Lisa Kailai Han, Sarah Min, Jesse Pound, Michelle Fox Organizations: Garmin, Caesars Entertainment, Google, Visa, AMD, Bloomberg, Emirates, Wall, Bank of America

☆ We reiterate our 1 rating on Microsoft despite its softer guidance — here's why
▼ + stars: | 2024-10-30 | by ( Jeff Marks | ) www.cnbc.com time to read: +7 min

Nearly 70% of the Fortune 500 is using Microsoft 365 Copilot and the company is seeing faster customer adoption than any other new Microsoft 365 Suite. MSFT YTD mountain Microsoft YTD Despite these positive trends and innovations, revenue guidance for next quarter fell a touch short of expectations. Microsoft 365 Commercial cloud revenue growth increased 16% year over year with seat growth up 8%. Microsoft 365 Consumer cloud revenue growth increased 7% year over year with subscribers increasing to 84.4 million from 82.4 million one quarter ago. Revenue growth ticked down sequentially to 33% annual growth, or 34% on a constant currency basis.

Persons: Nvidia's Blackwell, That's, —, Jim Cramer's, Jim Cramer, Jim, Microsoft Corporation Satya Nadella, Chalinee Thirasupa Organizations: Microsoft, Revenue, Fortune, Productivity, Dynamics, CNBC, Activision, Windows, Gaming, Microsoft Corporation Locations: OpenAI, Bangkok, Thailand

☆ Meta's stock drop tells the wrong story on earnings — so, we're boosting our price target
▼ + stars: | 2024-10-30 | by ( Zev Fima | ) www.cnbc.com time to read: +11 min

Don't let the after-hours stock action fool you, Meta Platforms delivered one heck of a strong third quarter and a current quarter revenue guide above expectations. Ok, now that the "bad" is out of the way, let's look at what investors should really be focused on as they consider what to do with Meta stock. Meta Platforms Why we own it : We value Meta Platforms for its targeted advertising dominance. Notably, Meta AI, the company's version of a ChatGPT-type generative artificial intelligence search/answer engine, now has over 500 million monthly active users. Looking ahead to 2025, the team noted on the release, "We continue to expect significant capital expenditures growth in 2025.

Persons: biggie, that's, China's ByteDance, Mark Zuckerberg, Jensen Huang, Zuckerberg, we're, Meta, it's, haven't, Jim Cramer's, Jim Cramer, Jim, Andrej Sokolow Organizations: LSEG, Meta, People, Management, China's, Reality Labs, Nvidia, ., Facebook, CNBC, Getty Locations: Ray, capex

☆ Reddit shares soar 40% on profitability, rosy guidance
▼ + stars: | 2024-10-30 | by ( Ashley Capoot | In | ) www.cnbc.com time to read: +2 min

Reddit CEO Steve Huffman hugs mascot Snoo as Reddit begins trading on the New York Stock Exchange on March 21, 2024. Shares of Reddit popped more than 40% on Wednesday, one day after the social media company posted a surprise profit in its third-quarter results and offered rosy guidance. Reddit said fourth-quarter revenue will be between $385 million and $400 million, above the average analyst estimate of $357.9 million. "It was another strong quarter for Reddit and our communities as we achieved important milestones, including new levels of user traffic, revenue growth, and profitability," Reddit CEO Steve Huffman said in a press release. They said they're encouraged by Reddit's strong revenue growth, improved profitability and growing daily active unique users.

Persons: Steve Huffman, Snoo, Reddit, JP Morgan, they're, Bernstein, Jekyll, Hyde, that's, Michael Bloom, Jonathan Vanian Organizations: New York Stock Exchange, LSEG, Citi, JP

☆ The Trump-linked stocks set to make wild moves as election approaches
▼ + stars: | 2024-10-30 | by ( Alex Harring | ) www.cnbc.com time to read: +6 min

Retail investors have increasingly focused in on Trump Media & Technology , Rumble and Phunware as stocks that can benefit if the Republican presidential nominee for president prevails. Trump Media & Technology, which owns the alternative social media platform TruthSocial, trades under a ticker — DJT — that's also the initials for the business mogul-turned-politician. On Tuesday alone, retail traders were net buyers of Trump Media to the tune of $14.4 million. Schwarz said there's no reason for Trump Media to even be publicly traded given its business fundamentals and high price-to-sales ratio. "Trump Media has no fundamental value — it's worthless," he said.

Persons: Donald Trump, That's, that's, Phunware, Kamala Harris, Christopher Schwarz, It's, Trump, There's, Irvine's Schwarz, Schwarz, there's, LSEG, hasn't, Peter Thiel, — CNBC's Robert Frank, Fred Imbert Organizations: Trump Media & Technology, Republican, Trump Media, NBC, University of California Irvine, CNBC, Vanda Research, U.S, Trump, Marriott, Mayo Clinic, PayPal Locations: United States, Atlantis

☆ Reddit just won earnings season with huge pop. What analysts see from here
▼ + stars: | 2024-10-30 | by ( Lisa Kailai Han | ) www.cnbc.com time to read: +3 min

Additionally, Reddit guided for fourth-quarter revenue of between $385 million and $400 million, while analysts had estimated an average of $357.9 million. Josey wrote that Reddit's continued user growth and engagement gains have boosted the company — and should continue to do so. JPMorgan analyst Doug Anmuth raised his price target to $110 from $77, while Bank of America analyst Justin Post lifted his target price to $99 from $84. These updated objectives respectively imply that Reddit stock could rise 35% and 21% from its Tuesday close. Shmulik's $85 price target, raised from $65, is just 4% higher than the stock's Tuesday closing price.

Persons: Reddit, LSEG, Ronald Josey, Josey, Reddit's, Morgan Stanley, Doug Anmuth, Justin Post, Brian Nowak's, Bernstein, Mark Shmulik, Shmulik, Jekyll, Hyde, that's Organizations: Citi, Bank of America, JPMorgan Locations: Reddit, Tuesday's

☆ Coinbase shares tumble as muted crypto trading leads to a third-quarter miss
▼ + stars: | 2024-10-30 | by ( Tanaya Macheel | ) www.cnbc.com time to read: +3 min

Monitors display Coinbase signage during the company's initial public offering (IPO) at the Nasdaq MarketSite in New York, on Wednesday, April 14, 2021. Coinbase Wednesday reported weaker-than-expected third-quarter results, weighed down by muted trading in the cryptocurrency market. Coinbase has been an active lobbyist for the crypto industry this year, spending millions backing pro-crypto political action committees. While crypto price action has been tepid, the market cap for stablecoins reached new highs, helping push Coinbase's third-quarter stablecoin revenue to $246.9 million. That revenue could be challenged in the current quarter with interest rates expected to continue coming down.

Persons: Bitcoin, Coinbase, Stablecoins, stablecoins Organizations: Nasdaq, Coinbase, LSEG, Revenue Locations: New York, U.S

☆ Eli Lilly stock tumbles 10% after drug giant misses estimates and slashes profit guidance
▼ + stars: | 2024-10-30 | by ( Annika Kim Constantino | ) www.cnbc.com time to read: +2 min

Eli Lilly on Wednesday fell short of profit and revenue expectations for the third quarter, weighed down by disappointing sales of its blockbuster weight loss drug Zepbound and diabetes treatment Mounjaro, and slashed its full-year adjusted profit guidance. Eli Lilly now expects full-year adjusted earnings of between $13.02 and $13.52 per share, down from previous guidance of $16.10 to $16.60 per share. Eli Lilly also lowered the high-end of its revenue outlook for the year and now expects sales of between $45.4 billion and $46 billion. The weekly injection raked in $1.26 billion in sales for the period, below the $1.76 billion that analysts expected, according to StreetAccount. As of Wednesday, the Food and Drug Administration's drug database said all doses of Zepbound and Mounjaro are available in the U.S. after extended shortages.

Persons: Eli Lilly, Mounjaro, Eli Lilly's Organizations: Novo Nordisk, LSEG, Food Locations: U.S

☆ Google 'moving in a good direction': What analysts are saying after tech giant's strong earnings
▼ + stars: | 2024-10-30 | by ( Lisa Kailai Han | ) www.cnbc.com time to read: +2 min

Major Wall Street banks remain bullish on Alphabet following the tech titan's strong third-quarter results . On Tuesday, Google's parent company reported earnings of $2.12 per share, while analysts polled by LSEG had predicted $1.85 per share. The company's revenue grew 15% year over year to $88.27 billion, more than the same quarter last year and the $86.30 billion analysts had anticipated. "We think shares could remain choppy as we work through the Search remedies, given the large impact zone, but performance in 3Q was solid." Meanwhile, Goldman Sachs' Eric Sheridan also commended the firm for its strong investment cycle, which includes investments into Google's Cloud infrastructure and more AI deployment through its application ecosystem.

Persons: LSEG, Goldman Sachs, Morgan Stanley, Ross Sandler, Doug Anmuth, Eric Sheridan Organizations: Barclays, Citi, JPMorgan, Bank of America, of America, Google, DOJ

☆ Biogen tops estimates, raises profit guidance as Alzheimer's drug Leqembi gains traction
▼ + stars: | 2024-10-30 | by ( Annika Kim Constantino | ) www.cnbc.com time to read: +2 min

A test tube is seen in front of displayed Biogen logo in this illustration taken on, December 1, 2021. Biogen on Wednesday reported third-quarter revenue and adjusted earnings that topped expectations while raising its full-year profit guidance, as sales of its breakthrough Alzheimer's drug, Leqembi, and other new products gain traction. Leqembi, which Biogen shares with the Japanese drugmaker Eisai, became the second drug proven to slow the progression of Alzheimer's to win approval in the U.S. last summer. The drug posted just $10 million in sales last year following its launch. That compares with a net loss of $68.1 million, or 47 cents per share, for the same period a year ago.

Persons: Biogen, StreetAccount Organizations: U.S, Wall Street, LSEG Locations: U.S

Search resuls for: "LSEG"

25 mentions found